Kiromic BioPharma Inc. (KRBP)
1.50
0.00 (0.00%)
At close: Feb 28, 2025, 3:17 PM
0.00
-100.00%
After-hours: Dec 31, 1969, 07:00 PM EST
No 1D chart data available
| Bid | n/a |
| Market Cap | 3.98M |
| Revenue (ttm) | n/a |
| Net Income (ttm) | -2.51M |
| EPS (ttm) | -3.17 |
| PE Ratio (ttm) | -0.47 |
| Forward PE | -0.52 |
| Analyst | n/a |
| Ask | n/a |
| Volume | 1 |
| Avg. Volume (20D) | 1,498 |
| Open | 1.50 |
| Previous Close | 1.50 |
| Day's Range | 1.50 - 1.50 |
| 52-Week Range | 0.75 - 3.65 |
| Beta | 1.84 |
About KRBP
Kiromic BioPharma, Inc., an artificial intelligence driven allogeneic cell therapy company, engages in developing the multi-indication allogeneic T cell therapies that exploits the natural potency of the Gamma Delta T cell to target solid tumors. The company develops ALEXIS-ISO-1, an allogenic gamma delta CAR-T cell therapy product candidate targeting Isomesothelin; and ALEXIS-PRO-1, an allogeneic gamma delta chimeric T cell therapy product candi...
Industry Biotechnology
Sector Healthcare
IPO Date Oct 16, 2020
Employees 44
Stock Exchange NASDAQ
Ticker Symbol KRBP
Website https://www.kiromic.com
2 months ago · businesswire.com
Kiromic BioPharma Announces Settlement of Previously Disclosed SEC InvestigationHOUSTON--(BUSINESS WIRE)---- $KRBP--Kiromic BioPharma, Inc. (OTCQB: KRBP) (“Kiromic” or the “Company”) today announced that it has entered into a settlement agreement with the U.S. Securities and Exch...
